Cargando…
The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers
PURPOSE: BRCA2 mutation carriers are offered annual breast screening with MRI and mammography. The aim of this study was to investigate the supplemental value of mammographic screening over MRI screening alone. METHODS: In this multicenter study, proven BRCA2 mutation carriers, who developed breast...
Autores principales: | Obdeijn, Inge-Marie, Mann, Ritse M., Loo, Claudette C. E., Lobbes, Marc, Voormolen, Eleonora M. C., van Deurzen, Carolien H. M., de Bock, Geertruida, Hooning, Maartje J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220868/ https://www.ncbi.nlm.nih.gov/pubmed/32333294 http://dx.doi.org/10.1007/s10549-020-05642-1 |
Ejemplares similares
-
Breast tumor characteristics of BRCA1 and BRCA2 gene mutation carriers on MRI
por: Veltman, J., et al.
Publicado: (2008) -
Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers
por: Heemskerk-Gerritsen, Bernadette A. M., et al.
Publicado: (2019) -
Survival of BRCA1/BRCA2-associated pT1 breast cancer patients, a cohort study
por: van Barele, Mark, et al.
Publicado: (2022) -
Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis
por: Phi, Xuan-Anh, et al.
Publicado: (2016) -
Mammographic screening detects low-risk tumor biology breast cancers
por: Drukker, C. A., et al.
Publicado: (2014)